Area of research
Immunology · Immunology and Allergy
Research interest
Research interests include Immune cells in cancer, Cell Adhesion Molecules Research, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, and Nanoplatforms for cancer theranostics.
Global marine microbial diversity and its potential in bioprospecting
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT
Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy
Association of tumor-infiltrating lymphocytes (TILs) with clinicopathologic characteristics and prognosis in young women with HR+/HER2- breast cancer (BC).
Colonic mucosal biopsy location can not affect the results of mucosal metabolomics and mucosal microbiota analysis in IBS
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial
Trajectories of fear of cancer recurrence in young breast cancer survivors
Association of Local Therapy With Quality-of-Life Outcomes in Young Women With Breast Cancer
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)
Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer
Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer
Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer